Drug Database · Clinicians

Guaifenesin + Phenylpropanolamine

Also known as: guaiphenesin (former British name, for guaifenesin)

Brands (3) Cherryl Expectorant, Coldrex-G, Ritusin PlusShow all

Decongestant / expectorant; Expectorant/Nasal decongestant; and others PH FDA category
Fixed-dose combination.

Controlled precursorOTC · Over-the-counter3 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 6.25 mg/100 mg per 5 mL, 100 mg/6.25 mg per 5 mL

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Guaifenesin + Phenylpropanolamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Guaifenesin + Phenylpropanolamine
Package insert
Cherryl ExpectorantPhenylpropanolamine Hydrochloride + Guaifenesin
6.25mg / 100mg per 5mL SyrupAmber Glass Bottle x 60 mL Box of 1's
OTC
Allied Pharmaceutical Laboratories, IncPhilippines
—
DR-552
Jul 24, 2029
Coldrex-GPhenylpropanolamine Hydrochloride + Guaifenesin
6.25 mg/100 mg per 5mL Syrup60mL Boston Round Amber Glass Bottle (Box of 1's)
OTC
New Myrex Laboratories, Inc.Bulacan
TGP Pharma Inc.
DRP-5202
Jul 12, 2037
Ritusin PlusGuaifenesin + Phenylpropanolamine Hydrochloride
100 mg/6.25 mg per 5 mL SyrupBoston Round Amber Bottle x 60 mL and 120 mL (Box of 1’s)
OTC
Diamond Laboratories Inc.Philippines
Rilem Pharma Corp.
DRP-6993
Apr 1, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .